logo

For the Inventor, By the Inventor

Ahmedabad, India

Manish Kumar Umrethia

This inventor holds 41 USPTO granted patents and 21 published patent applications and 2 EPO patents, primarily in Liquid Oral Formulations. Top assignees: Liqmeds Worldwide Limited, Azurity Pharmaceuticals, Inc., Ftf Pharma Private Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manish Kumar Umrethia. Retrieved from https://idiyas.com/inventor/manish-kumar-umrethia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal26 out of 40 
 
Liqmeds Worldwide Limited
 patents
silverMedal4 out of 51 
 
Azurity Pharmaceuticals, Inc.
 patents
bronzeMedal4 out of 5 
 
Ftf Pharma Private Limited
 patents
4. 4 out of 20 
 
Norbrook Laboratories Limited
 patents
5. 2 out of 6 
 
Lm Manufacturing
 patents
6. 2 out of 3 
 
Oncosol Limited
 patents
7. 1 out of 4 
 
Shorla Pharma Limited
 patents
where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
PDE V Inhibitors
Zonisamide
Rivaroxaban
Clonidine
Vigabatrin
Losartan
Mycophenolate
Imatinib
Chemotherapeutic Suspension
Oral Dosage
Pharmaceutical Composition
Thioureylene
41 patents (USPTO):Explore Patents
1. 12751947 - Oral liquid formulation of apixaban (2026-10-06),
2. 12734175 - Liquid oral formulations for PDE V inhibitors (2026-09-15),
3. 12721849 - Liquid oral formulations for PDE V inhibitors (2026-09-01),
4. 12708626 - LIQUID ORAL FORMULATIONS FOR TADALAFIL (2026-08-18),
5. 12697338 - Liquid oral formulations for PDE V inhibitors (2026-08-04),
6. 12691120 - Liquid oral formulations for PDE V inhibitors (2026-07-28),
7. 12685723 - Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof (2026-07-21),
8. 12648950 - Oral liquid formulation of rivaroxaban (2026-06-09),
9. 12551466 - Ready-to-use oral liquid formulation of clonidine (2026-02-17),
10. 12539300 - Method of treating seizures and epilepsy using liquid pharmaceutical composition for oral dosage of vigabatrin (2026-02-03),
11. 12496291 - Ready-to-use non-aqueous oral solution of losartan (2025-12-16),
12. 12491179 - Oral pharmaceutical composition comprising zonisamide and process of preparation thereof (2025-12-09),
13. 12343338 - Ramipril solution for oral dosage (2025-07-01),
14. 12303504 - Non-aqueous chemotherapeutic suspensions for oral dosage (2025-05-20),
15. 12251361 - Solutions for oral dosage (2025-03-18),

Title: Inventor Manish Kumar Umrethia

Introduction: Manish Kumar Umrethia is a prolific inventor based in Ahmedabad, India, known for his innovative contributions in various fields.

Latest Patents: Manish Kumar Umrethia holds several patents in the areas of technology and healthcare, showcasing his diverse range of expertise.

Career Highlights: With a successful career spanning over two decades, Manish Kumar Umrethia has worked on groundbreaking projects that have significantly impacted the industries he is involved in.

Collaborations: Throughout his career, Manish Kumar Umrethia has collaborated with leading researchers, scientists, and companies to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Manish Kumar Umrethia's dedication to pushing the boundaries of technology and healthcare through his inventive spirit continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…